Literature DB >> 32205563

Deficiency of cysteinyl cathepsin K suppresses the development of experimental intimal hyperplasia in response to chronic stress.

Xiangkun Meng1,2, Limei Piao1,2, Hailong Wang1, Aiko Inoue2,3, Zhe Huang1, Haiying Jiang4, Kae Nakamura5, Takeshi Sasaki6, Xiang Li1, Wenhu Xu1, Chenglin Yu1, Lina Hu7, Hongxian Wu8, Toyoaki Murohara9, Guo-Ping Shi10, Masafumi Kuzuya2,3, Xian Wu Cheng1,2,3.   

Abstract

BACKGROUND: Chronic psychological stress (CPS) is linked to cardiovascular disease initiation and progression. Given that cysteinyl cathepsin K (CatK) participates in vascular remodeling and atherosclerotic plaque growth in several animal models, we investigated the role of CatK in the development of experimental neointimal hyperplasia in response to chronic stress. METHODS AND
RESULTS: At first, male wild-type (CatK) mice that underwent carotid ligation injury were subjected to chronic immobilization stress. On postoperative and stressed day 14, the results demonstrated that stress accelerated injury-induced neointima hyperplasia. On day 4, stressed mice showed following: increased levels of monocyte chemoattractant protein-1, gp91phox, toll-like receptor-2 (TLR2), TLR4, and CatK mRNAs or/and proteins, oxidative stress production, aorta-derived smooth muscle cell (SMC) migration, and macrophage infiltration as well as targeted intracellular proliferating-related molecules. Stressed mice showed increased matrix metalloproteinase-2 (MMP-2) and MMP-9 mRNA expressions and activities and elastin disruption in the injured carotid arteries. Second, CatK and CatK deficiency (CatK) mice received ligation injury and stress to explore the role of CatK. The stress-induced harmful changes were prevented by CatK. Finally, CatK mice that had undergone ligation surgery were randomly assigned to one of two groups and administered vehicle or CatK inhibitor for 14 days. Pharmacological CatK intervention produced a vascular benefit.
CONCLUSION: These data indicate that CatK deletion protects against the development of experimental neointimal hyperplasia via the attenuation of inflammatory overaction, oxidative stress production, and VSMC proliferation, suggesting that CatK is a novel therapeutic target for the management of CPS-related restenosis after intravascular intervention therapies.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32205563     DOI: 10.1097/HJH.0000000000002424

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

1.  Cathepsin K Deficiency Prevented Kidney Damage and Dysfunction in Response to 5/6 Nephrectomy Injury in Mice With or Without Chronic Stress.

Authors:  Xueling Yue; Limei Piao; Hailong Wang; Zhe Huang; Xiangkun Meng; Takeshi Sasaki; Aiko Inoue; Kae Nakamura; Ying Wan; Shengnan Xu; Guo-Ping Shi; Weon Kim; Toyoaki Murohara; Masafumi Kuzuya; Xian Wu Cheng
Journal:  Hypertension       Date:  2022-06-21       Impact factor: 9.897

2.  Chlamydia pneumoniae Infection Induces Vascular Smooth Muscle Cell Migration and Atherosclerosis Through Mitochondrial Reactive Oxygen Species-Mediated JunB-Fra-1 Activation.

Authors:  Xi Zhao; Guolin Miao; Lijun Zhang; Yuke Zhang; Huanhuan Zhao; Zhelong Xu; Beibei Wang; Lijun Zhang
Journal:  Front Cell Dev Biol       Date:  2022-04-12

3.  IRF-1 contributes to the pathological phenotype of VSMCs during atherogenesis by increasing CCL19 transcription.

Authors:  Yongbin Shen; Zhanfeng Sun; Shuran Mao; Yingnan Zhang; Weiliang Jiang; Haitao Wang
Journal:  Aging (Albany NY)       Date:  2020-11-16       Impact factor: 5.682

Review 4.  Recent Progress of Chronic Stress in the Development of Atherosclerosis.

Authors:  Shang Gao; Xiang Wang; Ling-Bing Meng; Yuan-Meng Zhang; Yue Luo; Tao Gong; De-Ping Liu; Zuo-Guan Chen; Yong-Jun Li
Journal:  Oxid Med Cell Longev       Date:  2022-03-08       Impact factor: 6.543

5.  Proliferin-1 Ameliorates Cardiotoxin-Related Skeletal Muscle Repair in Mice.

Authors:  Hiroki Goto; Aiko Inoue; Limei Piao; Lina Hu; Zhe Huang; Xiangkun Meng; Yusuke Suzuki; Hiroyuki Umegaki; Masafumi Kuzuya; Xian Wu Cheng
Journal:  Stem Cells Int       Date:  2021-11-20       Impact factor: 5.443

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.